Stephen Mullennix, Chief Operating Officer at UroGen Pharma Ltd. (URGN), sold 608 shares at $37.98 ($23K) on 2019-05-14, disclosed to the SEC on 2019-05-16.
Open-market sale of $23k URGN by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2020-01-28 | $20K | — | Filing → |
| URGN | SELL | 2019-11-18 | $16K | — | Filing → |
| URGN | SELL | 2019-08-16 | $19K | — | Filing → |